Covered recipient · General Payments record
DANIEL KAPLAN
General Payments · PY2018–2024
$6,630.03
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,254.82 | 56 |
| Education | $79.80 | 1 |
| Long term medical supply or device loan | $49.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $162.62 | 7 |
| Radius Health, Inc. | $144.30 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $126.27 | 5 |
| Novo Nordisk AS | $91.45 | 5 |
| Merck Sharp & Dohme Corporation | $87.91 | 3 |
| ABBVIE INC. | $78.61 | 3 |
| PFIZER INC. | $68.42 | 3 |
| SANOFI-AVENTIS U.S. LLC | $61.78 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.68 | 3 |
| Kyowa Kirin, Inc. | $56.12 | 3 |
| DEXCOM, INC. | $54.50 | 3 |
| Abbott Laboratories | $49.95 | 1 |
| Lilly USA, LLC | $49.68 | 2 |
| Ascensia Diabetes Care US Inc. | $48.89 | 2 |
| Acerta Pharma LLC | $35.91 | 2 |
| Integra LifeSciences Corporation | $30.85 | 1 |
| Edwards Lifesciences Corporation | $24.87 | 1 |
| Pharmacosmos Therapeutics Inc. | $23.91 | 1 |
| Medtronic, Inc. | $23.40 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.81 | 1 |
| DAVOL INC. | $22.60 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.58 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $21.03 | 1 |
| Tandem Diabetes Care, Inc. | $18.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (58)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.